These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5322648)

  • 41. Can psychedelics have a role in psychiatry once again?
    Sessa B
    Br J Psychiatry; 2005 Jun; 186():457-8. PubMed ID: 15928353
    [No Abstract]   [Full Text] [Related]  

  • 42. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness.
    Rosa WE; Dorsen CG; Penn A
    J Palliat Med; 2020 Oct; 23(10):1288-1289. PubMed ID: 33001753
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1968; 23():563-81. PubMed ID: 4890081
    [No Abstract]   [Full Text] [Related]  

  • 45. Observation on two psychotomimetic drugs of piperidine derivation--CI 395 (sernyl) and CI 400.
    LEVY L; CAMERON DE; AITKEN RC
    Am J Psychiatry; 1960 Mar; 116():843-4. PubMed ID: 14416411
    [No Abstract]   [Full Text] [Related]  

  • 46. The therapeutic potential of psychedelics.
    Schindler EAD; D'Souza DC
    Science; 2022 Dec; 378(6624):1051-1053. PubMed ID: 36480624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. THE PSYCHOTOMIMETIC DRUGS. AN OVERVIEW.
    COLE JO; KATZ MM
    JAMA; 1964 Mar; 187():758-61. PubMed ID: 14094299
    [No Abstract]   [Full Text] [Related]  

  • 48. COMPARISON OF TWO DRUGS WITH PSYCHOTOMIMETIC EFFECTS (LSD AND DITRAN).
    WILSON RE; SHAGASS C
    J Nerv Ment Dis; 1964 Mar; 138():277-86. PubMed ID: 14130138
    [No Abstract]   [Full Text] [Related]  

  • 49. A protocol for the evaluation of new psychoactive drugs in man.
    Shulgin AT; Shulgin LA; Jacob P
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):313-20. PubMed ID: 3724306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use and abuses of drugs in psychiatry.
    Shepherd M
    Lancet; 1970 Jan; 1(7636):31-3. PubMed ID: 4188353
    [No Abstract]   [Full Text] [Related]  

  • 51. Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.
    Thomas K; Malcolm B; Lastra D
    J Psychoactive Drugs; 2017; 49(5):446-455. PubMed ID: 28481178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
    Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
    Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
    [No Abstract]   [Full Text] [Related]  

  • 53. (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.
    Pitts EG; Curry DW; Hampshire KN; Young MB; Howell LL
    Psychopharmacology (Berl); 2018 Feb; 235(2):377-392. PubMed ID: 29248945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of neuroleptics on the excretion of hallucinogens].
    Kanabus P; Stencka K
    Psychiatr Pol; 1974; 8(2):163-8. PubMed ID: 4830324
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
    Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
    Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Principles of testing psychotherapeutic drugs].
    Arnold OH
    Act Nerv Super (Praha); 1967 Feb; 9(1):30-8. PubMed ID: 5340116
    [No Abstract]   [Full Text] [Related]  

  • 59. Back to the Future - The Therapeutic Potential of Psychedelic Drugs.
    Lieberman JA
    N Engl J Med; 2021 Apr; 384(15):1460-1461. PubMed ID: 33852784
    [No Abstract]   [Full Text] [Related]  

  • 60. A regulatory perspective on the evaluation of hallucinogen drugs for human use.
    Calderon SN; Hunt J; Klein M
    Neuropharmacology; 2018 Nov; 142():135-142. PubMed ID: 29180224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.